Filing Flows › Opus Genetics (IRD) › Q2 2026 › vs Q1 2026
Opus Genetics (IRD) Q2 2026 vs Q1 2026 (quarter over quarter)
Opus Genetics's revenue fell $1.4M (-65%) from $2.2M in Q1 2026 to $755K in Q2 2026.
Opus Genetics, Q2 2026: revenue $755K (-74% year over year), net loss $8.1M, operating cash flow −$11.9M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $755K | $2.2M | −$1.4M | -65% |
| Other income, net | $8.4M | −$51.2M | $59.6M | — |
| Net loss | $8.1M | $65.5M | −$57.4M | -88% |
| Costs & expenses | $17.2M | $67.7M | −$50.5M | -75% |
| Operating costs | $17.2M | $16.5M | $714K | +4% |
| Research & development | $11.2M | $10.6M | $630K | +6% |
| General & admin | $6.0M | $5.9M | $84K | +1% |
| Operating cash sources | $13.4M | $14.2M | −$833K | -6% |
| Depreciation | $14K | $13K | $1K | +8% |
| Share-based compensation | $1.4M | $1.5M | −$57K | -4% |
| Cash used in operations | $11.9M | $12.7M | −$777K | -6% |
| Net loss absorbed | $8.1M | $65.5M | −$57.4M | -88% |
| Working capital & other | $5.3M | −$51.3M | $56.6M | — |
Questions
How much did Opus Genetics's revenue grow quarter over quarter in Q2 2026?
Opus Genetics's revenue fell $1.4M (-65%) from $2.2M in Q1 2026 to $755K in Q2 2026.